期刊文献+

HPLC法测定二氟尼柳缓释片中二氟尼柳含量

Determination of diflunisal in diflunisal sustained release tablets by HPLC
下载PDF
导出
摘要 目的建立二氟尼柳缓释片中二氟尼柳含量测定的HPLC法。方法 C18色谱柱(4.6 mm×250 mm,5μm),流动相为甲醇-乙腈-水-冰醋酸(30∶70∶50∶2),检测波长为254 nm,流速为1.5 mL/min,柱温为室温,进样量为10μL。结果二氟尼柳检测浓度的线性范围为7.5~52.5μg/mL(r=0.999 9),平均回收率为99.93%,RSD=0.76%。结论本方法准确、可靠,重现性好,可用于二氟尼柳缓释片中二氟尼柳的含量测定。 Objective To establish an HPLC method for determination of the diflunisal content in diflunisal sustained release tablets. Methods The quantitative analysis was performed on a Hypersil DBS C18 column(4. 6 mm x 250 mm,5 μm). The mobile phase was methanol-methyl cyanides-water-glacial acetic acid ( 30: 70: 50:2 ) with the flow rate of 1.5 mL/min. The detective wavelength was 254 nm at room temperature. Results The linear range of difluni- sal was 7.5 - 52. 5 g/mL (r = 0. 999 9 ). The average recovery was 99.93 % , and RSD was 0. 76%. Conclusion The method is accurate and reliable with good reproducibility,it could be used for the quality control for the preparation.
作者 田甜 刘德孝
出处 《实用药物与临床》 CAS 2013年第2期133-134,共2页 Practical Pharmacy and Clinical Remedies
关键词 二氟尼柳缓释片 二氟尼柳 HPLC法 含量测定 Diflunisal sustained release tablets Diflunisal HPLC Content determination
  • 相关文献

参考文献9

  • 1胡红丹,茅松青,钟光祥.二氟尼柳衍生物的研究进展[J].浙江化工,2010,41(3):1-4. 被引量:6
  • 2Fountoulaki S, Perdih F, Turel L, et al. Non-steroidal anti-in- flammatory drug diflunisal interacting with Cu ( II ). Structure and biological features [ J ]. J Inorg Biochem, 2011,105 (12 ) : 1645-1655.
  • 3Sekijima Y. Familial amyloid polyneuropathy: diflunisal[J]. Rinsho Shinkeiqaku ,2010,50( 11 ) :836.
  • 4Berk JL, Dyck PJ, Obici L, et al. The diflunisal trial: update on study drug tolerance and disease progression [J ]. Amyloid, 2011,18(S1 ) :191-192.
  • 5Wasey JO, Derry S, Moore RA, et al. Single dose oral diflunisal for acute postoperative pain in adults [ J ]. Cochrane Database Syst Rev, 2010,14 (4) : CD007440.
  • 6Ward KE,Archambault R,Mersfelder TL. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs:A review of the literature[J]. Am J Health Syst Pharm,2010,67(3) :206-213.
  • 7Wahbi AA, Mabrouk MM, Moneeb MS, et al. Simultaneous de- termination of the two non-steroidal anti-inflammatory drugs;di- flunisal and naproxen in their tablets by chemometric spectropho- tometry and HPLC[J]. Pak J Pharm Sci,2009,22( 1 ) :8-17.
  • 8黄华,余小平,田海.HPLC法测定二氟尼柳胶囊中二氟尼柳的含量[J].临床合理用药杂志,2009,2(17):14-15. 被引量:2
  • 9王玉花,刘晓磊,孙文慧,孟琴,彭文兴.二氟尼柳分散片的人体药动学及生物等效性[J].中国医院药学杂志,2007,27(2):196-198. 被引量:2

二级参考文献28

  • 1冯雪松,刘雅茹,王立坤,孟繁浩.二氟尼柳的药理作用与临床应用[J].山西医药杂志,2005,34(6):486-487. 被引量:8
  • 2Claudio G,Laura C,Francesco M.Process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid:EP,0494419[P]1992-07-15.
  • 3Hannah J,Ruyle WV,Jones H,et al.Discovery of Diflunisal[J].Br J clin Pharmac,1977,4:7-13.
  • 4胡金清.二氟尼柳酰胺衍生物的合成及生物活性研究[D].浙江省杭州市:浙江工业大学,2009.
  • 5Stradi R.Imidazolium salt of 2,4-difluo-4-hydroxydiphenyl-3-carboxylicacid:GB,2174699[P].1986-11-12.
  • 6Brugioni M,Fedi M.Anti-inflammatory,analgesic,antipyretic,water-soluble compound and process for its preparation:GB,2101135[P].1983-01-12.
  • 7Yu C X.Positively charged water-soluble prodrugs of Diflunisal and related compounds with very fast skin penetration rate:WO,2008012603[P].2008-01-31.
  • 8Hung Y D,Mellick D G,Prankerd J R,et al.Synthesis,identification,characterization,stability,solubility,and protein binding of ester derivatives of salicylic acid and Diflunisal[J].Int J Pharm,1997,153:25-39.
  • 9Hung Y D,Roberts S M.Novel Diflunisal esters and related compounds:US,2003220497[P].2003-11-27.
  • 10Kücükgüzel G S,Mazi A,Sahin F,et al.Synthesis and biological activities of Diflunisal hydrazide-hydrazones[J].Eur J Med Chem,2003,38:1005-1013.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部